Fig. 4From: Integrated analyzes identify CCT3 as a modulator to shape immunosuppressive tumor microenvironment in lung adenocarcinomaAssociation of CCT3 expression with clinicopathologic characteristics. CCT3 mRNA level was compared between T- (a), N- (b) and M-categories (c), pathologic stages (d), smokers and non-smokers (e), male and female (f), and ≤ 65 and > 65 of LUAD patients. (g) *P < 0.05; ***P < 0.001; ns, no significanceBack to article page